Your browser doesn't support javascript.
loading
Validation analysis of the novel imaging-based prognostic radiomic signature in patients undergoing primary surgery for advanced high-grade serous ovarian cancer (HGSOC).
Fotopoulou, Christina; Rockall, Andrea; Lu, Haonan; Lee, Philippa; Avesani, Giacomo; Russo, Luca; Petta, Federica; Ataseven, Beyhan; Waltering, Kai-Uwe; Koch, Jens Albrecht; Crum, William R; Cunnea, Paula; Heitz, Florian; Harter, Philipp; Aboagye, Eric O; du Bois, Andreas; Prader, Sonia.
Afiliação
  • Fotopoulou C; Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, W12 0HS, UK. c.fotopoulou@imperial.ac.uk.
  • Rockall A; Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, W12 0HS, UK.
  • Lu H; Department of Radiology, Imperial College Healthcare NHS Trust, London, W12 0HS, UK.
  • Lee P; Cancer Imaging Centre, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, W12 0HS, UK.
  • Avesani G; Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, W12 0HS, UK.
  • Russo L; Department of Radiology, Imperial College Healthcare NHS Trust, London, W12 0HS, UK.
  • Petta F; Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, W12 0HS, UK.
  • Ataseven B; Cancer Imaging Centre, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, W12 0HS, UK.
  • Waltering KU; Department of Imaging, Oncological Radiotherapy, and Hematology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Koch JA; Department of Imaging, Oncological Radiotherapy, and Hematology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Crum WR; Department of Imaging, Oncological Radiotherapy, and Hematology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Cunnea P; Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Henricistr.92, 45136, Essen, Germany.
  • Heitz F; Department of Obstetrics and Gynecology, University Hospital, LMU Munich, München, Germany.
  • Harter P; Department of Radiology, Kliniken Essen-Mitte, Henricistr.92, 45136, Essen, Germany.
  • Aboagye EO; Department of Radiology, Kliniken Essen-Mitte, Henricistr.92, 45136, Essen, Germany.
  • du Bois A; Cancer Imaging Centre, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, W12 0HS, UK.
  • Prader S; Institute of Translational Medicine and Therapeutics (ITMAT), Imperial College, London, UK.
Br J Cancer ; 126(7): 1047-1054, 2022 04.
Article em En | MEDLINE | ID: mdl-34923575
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Recidiva Local de Neoplasia Tipo de estudo: Observational_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Br J Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Recidiva Local de Neoplasia Tipo de estudo: Observational_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Br J Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido